The synthesis and evaluation of indolylureas as PKCα inhibitors

被引：6

作者：

Djung, Jane F. ^{[2
]}

Mears, Richard. J. ^{[1
]}

Montalbetti, Christian A. G. N. ^{[1
]}

Coulter, Thomas S. ^{[1
]}

Golebiowski, Adam ^{[2
]}

Carr, Andrew N. ^{[2
]}

Barker, Oliver ^{[1
]}

Greis, Kenneth D. ^{[2
]}

Zhou, Songtao ^{[2
]}

Dolan, Elizabeth ^{[2
]}

Davis, Gregory F. ^{[2
]}

机构：

[1] Evotec, Abingdon OX14 4SA, Oxon, England

[2] Procter & Gamble Pharmaceut Inc, Hlth Care Res Ctr, Mason, OH 45040 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2011年 / 19卷 / 08期

关键词：

Protein kinase C alpha; Kinase inhibitor; Heart disease; Indolylurea; PROTEIN-KINASE-C; MOLECULAR-FORCE FIELD; CARDIAC CONTRACTILITY; HEART-FAILURE; POTENT; DESIGN; THETA; DISEASE; BINDING; GEOMETRIES;

D O I：

10.1016/j.bmc.2011.02.036

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

PKC alpha and PKA have crucial but opposing roles in the regulation of calcium handling within myocytes. Identification of compounds that inhibit PKC alpha, but not PKA, are potential therapeutic targets for the treatment of heart disease. The synthesis of indolylureas are described, and a compound displaying nanomolar inhibition towards PKC alpha with significant selectivity over PKA has been identified. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：2742 / 2750

页数：9

共 93 条

[81] SAR studies, and pharmacological evaluation of 3-anilino-4-(3-indolyl) maleimides with conformationally restricted structure as orally bioavailable PKCβ-selective inhibitors [J].

Tanaka, Masahiro ;

Sagawa, Shoichi ;

Hoshi, Jun-ichi ;

Shimoma, Fumito ;

Yasue, Katsutaka ;

Ubukata, Minoru ;

Ikemoto, Tomoyuki ;

Hase, Yasunori ;

Takahashi, Mitsuru ;

Sasase, Tomohiko ;

Ueda, Nobuhisa ;

Matsushita, Mutsuyoshi ;

Inaba, Takashi .

BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (17) :5781-5794

[82] On the Origins of Enzyme Inhibitor Selectivity and Promiscuity: A Case Study of Protein Kinase Binding to Staurosporine [J].

Tanramluk, Duangrudee ;

Schreyer, Adrian ;

Pitt, William R. ;

Blundell, Tom L. .

CHEMICAL BIOLOGY & DRUG DESIGN, 2009, 74 (01) :16-24

[83] Heart disease and stroke statistics - 2006 update - A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [J].

Thom, T ;

Haase, N ;

Rosamond, W ;

Howard, VJ ;

Rumsfeld, J ;

Manolio, T ;

Zheng, ZJ ;

Flegal, K ;

O'Donnell, C ;

Kittner, S ;

Lloyd-Jones, D ;

Goff, DC ;

Hong, YL ;

Adams, R ;

Friday, G ;

Furie, K ;

Gorelick, P ;

Kissela, B ;

Marler, J ;

Meigs, J ;

Roger, V ;

Sidney, S ;

Sorlie, P ;

Steinberger, J ;

Wasserthiel-Smoller, S ;

Wilson, M ;

Wolf, P .

CIRCULATION, 2006, 113 (06) :E85-E151

[84] 2-(6-Phenyl-1H-indazol-3-yl)-1H-benzo[d]imidazoles: Design and synthesis of a potent and isoform selective PKC-ζ inhibitor [J].

Trujillo, John I. ;

Kiefer, James R. ;

Huang, Wei ;

Thorarensen, Atli ;

Xing, Li ;

Caspers, Nicole L. ;

Day, Jacqueline E. ;

Mathis, Karl J. ;

Kretzmer, Kuniko K. ;

Reitz, Beverley A. ;

Weinberg, Robin A. ;

Stegeman, Roderick A. ;

Wrightstone, Ann ;

Christine, Lori ;

Compton, Robert ;

Li, Xiong .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) :908-911

[85]

VINCINI P, 2006, EUR J MED CHEM, V41, P624

[86] Discovery of 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a Potent and Selective Inhibitor of Protein Kinase C Isotypes [J].

Wagner, Juergen ;

von Matt, Peter ;

Sedrani, Richard ;

Albert, Rainer ;

Cooke, Nigel ;

Ehrhardt, Claus ;

Geiser, Martin ;

Rummel, G'abriele ;

Stark, Wilhelm ;

Strauss, Andre ;

Cowan-Jacob, Sandra W. ;

Beerli, Christian ;

Weckbecker, Gisbert ;

Evenou, Jean-Pierre ;

Zenke, Gerhard ;

Cottens, Sylvain .

JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (20) :6193-6196

[87]

WARD TJ, 1991, Patent No. 4983600

[88] Synthesis and PKC binding of a new class of A-ring diversifiable bryostatin analogues utilizing a double asymmetric hydrogenation and cross-coupling strategy [J].

Wender, Paul A. ;

Horan, Joshua C. .

ORGANIC LETTERS, 2006, 8 (20) :4581-4584

[89] PROTEIN-KINASE C-ALPHA INHIBITORS - STRUCTURE-ACTIVITY-RELATIONSHIPS IN BIS-INDOLE SERIES [J].

XIE, GJ ;

ZIMMERMANN, J ;

MEYER, T ;

LOWN, JW .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (05) :497-500

[90] Catalytic domain crystal structure of protein kinase C-θ (PKC θ) [J].

Xu, ZB ;

Chaudhary, D ;

Olland, S ;

Wolfrom, S ;

Czerwinski, R ;

Malakian, K ;

Lin, L ;

Stahl, ML ;

McCarthy, DJ ;

Benander, C ;

Fitz, L ;

Greco, R ;

Somers, WS ;

Mosyak, L .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (48) :50401-50409

← 1 2 3 4 5 6 7 8 9 10 →